Tectonic Therapeutic (TECX) Competitors $22.40 +0.85 (+3.94%) Closing price 04:00 PM EasternExtended Trading$21.46 -0.94 (-4.19%) As of 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TECX vs. EWTX, IMCR, TVTX, MESO, GPCR, JANX, EVO, SPRY, ADPT, and VERAShould you be buying Tectonic Therapeutic stock or one of its competitors? The main competitors of Tectonic Therapeutic include Edgewise Therapeutics (EWTX), Immunocore (IMCR), Travere Therapeutics (TVTX), Mesoblast (MESO), Structure Therapeutics (GPCR), Janux Therapeutics (JANX), Evotec (EVO), ARS Pharmaceuticals (SPRY), Adaptive Biotechnologies (ADPT), and Vera Therapeutics (VERA). These companies are all part of the "pharmaceutical products" industry. Tectonic Therapeutic vs. Edgewise Therapeutics Immunocore Travere Therapeutics Mesoblast Structure Therapeutics Janux Therapeutics Evotec ARS Pharmaceuticals Adaptive Biotechnologies Vera Therapeutics Edgewise Therapeutics (NASDAQ:EWTX) and Tectonic Therapeutic (NASDAQ:TECX) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, earnings, valuation, community ranking, profitability, risk and dividends. Does the media prefer EWTX or TECX? In the previous week, Edgewise Therapeutics had 6 more articles in the media than Tectonic Therapeutic. MarketBeat recorded 8 mentions for Edgewise Therapeutics and 2 mentions for Tectonic Therapeutic. Edgewise Therapeutics' average media sentiment score of 1.66 beat Tectonic Therapeutic's score of 1.55 indicating that Edgewise Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Edgewise Therapeutics 6 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Tectonic Therapeutic 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has more risk & volatility, EWTX or TECX? Edgewise Therapeutics has a beta of 0.36, indicating that its share price is 64% less volatile than the S&P 500. Comparatively, Tectonic Therapeutic has a beta of 3.44, indicating that its share price is 244% more volatile than the S&P 500. Do analysts prefer EWTX or TECX? Edgewise Therapeutics currently has a consensus target price of $40.22, suggesting a potential upside of 177.22%. Tectonic Therapeutic has a consensus target price of $79.20, suggesting a potential upside of 257.40%. Given Tectonic Therapeutic's stronger consensus rating and higher possible upside, analysts plainly believe Tectonic Therapeutic is more favorable than Edgewise Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Edgewise Therapeutics 0 Sell rating(s) 2 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.78Tectonic Therapeutic 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.14 Does the MarketBeat Community prefer EWTX or TECX? Edgewise Therapeutics received 29 more outperform votes than Tectonic Therapeutic when rated by MarketBeat users. However, 100.00% of users gave Tectonic Therapeutic an outperform vote while only 72.73% of users gave Edgewise Therapeutics an outperform vote. CompanyUnderperformOutperformEdgewise TherapeuticsOutperform Votes4072.73% Underperform Votes1527.27% Tectonic TherapeuticOutperform Votes11100.00% Underperform VotesNo Votes Is EWTX or TECX more profitable? Edgewise Therapeutics' return on equity of -26.83% beat Tectonic Therapeutic's return on equity.Company Net Margins Return on Equity Return on Assets Edgewise TherapeuticsN/A -26.83% -25.67% Tectonic Therapeutic N/A -35.53%-31.97% Which has better valuation and earnings, EWTX or TECX? Edgewise Therapeutics is trading at a lower price-to-earnings ratio than Tectonic Therapeutic, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEdgewise TherapeuticsN/AN/A-$100.16M-$1.55-9.36Tectonic TherapeuticN/AN/A$12.16M-$7.31-3.03 Do institutionals & insiders believe in EWTX or TECX? 62.6% of Tectonic Therapeutic shares are held by institutional investors. 23.2% of Edgewise Therapeutics shares are held by company insiders. Comparatively, 38.0% of Tectonic Therapeutic shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. SummaryTectonic Therapeutic beats Edgewise Therapeutics on 9 of the 16 factors compared between the two stocks. Get Tectonic Therapeutic News Delivered to You Automatically Sign up to receive the latest news and ratings for TECX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TECX vs. The Competition Export to ExcelMetricTectonic TherapeuticBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$413.79M$2.99B$5.38B$8.52BDividend YieldN/A1.65%5.29%4.18%P/E Ratio-3.7631.7927.0619.78Price / SalesN/A428.37403.04137.40Price / CashN/A168.6838.2534.64Price / Book10.403.266.804.55Net Income$12.16M-$72.35M$3.22B$247.76M7 Day Performance-0.18%1.29%2.08%2.21%1 Month Performance9.54%3.05%10.14%10.50%1 Year PerformanceN/A-17.73%20.91%10.71% Tectonic Therapeutic Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TECXTectonic Therapeutic2.9844 of 5 stars$22.40+3.9%$79.20+253.6%N/A$418.28MN/A-3.80120Positive NewsEWTXEdgewise Therapeutics3.272 of 5 stars$14.79+0.1%$40.22+172.0%-18.5%$1.55BN/A-9.8660Positive NewsGap DownIMCRImmunocore3.0023 of 5 stars$31.00+2.1%$58.13+87.5%-32.0%$1.52B$333.58M-32.63320News CoveragePositive NewsAnalyst ForecastTVTXTravere Therapeutics2.869 of 5 stars$17.01+1.3%$31.79+86.9%+121.2%$1.51B$273.53M-4.15460Positive NewsMESOMesoblast1.6982 of 5 stars$11.55-1.5%$18.00+55.8%+28.5%$1.48B$5.67M0.0080News CoverageGap DownGPCRStructure Therapeutics2.3086 of 5 stars$25.00-0.7%$78.00+212.0%-40.1%$1.43BN/A-33.78136JANXJanux Therapeutics2.1265 of 5 stars$24.17-0.5%$95.25+294.1%-49.9%$1.43B$9.34M-20.6630Positive NewsShort Interest ↑Gap DownEVOEvotec1.763 of 5 stars$3.97-2.2%$5.93+49.5%-18.5%$1.41B$788.22M0.004,200SPRYARS Pharmaceuticals2.5062 of 5 stars$14.26+4.9%$31.00+117.4%+65.4%$1.40B$89.15M-27.9690ADPTAdaptive Biotechnologies3.1962 of 5 stars$9.20+1.7%$9.83+6.9%+150.7%$1.40B$189.53M-8.44790Positive NewsVERAVera Therapeutics2.3511 of 5 stars$21.01-1.1%$63.33+201.4%-49.2%$1.35BN/A-8.0540Positive NewsShort Interest ↑ Related Companies and Tools Related Companies Edgewise Therapeutics Competitors Immunocore Competitors Travere Therapeutics Competitors Mesoblast Competitors Structure Therapeutics Competitors Janux Therapeutics Competitors Evotec Competitors ARS Pharmaceuticals Competitors Adaptive Biotechnologies Competitors Vera Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TECX) was last updated on 5/29/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tectonic Therapeutic Please log in to your account or sign up in order to add this asset to your watchlist. Share Tectonic Therapeutic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TECX Stock Free TECX Stock Alerts